Six companies went public, making it the year's second most-active week. Coupa Software was the latest software IPO to price above its range and pop on the first day (+85%) as IPO investors continue to embrace high growth and strong margins, offered at a...read more
Obalon Therapeutics, which is commercializing an intragastric balloon device designed to assist with weight loss, raised $75 million by offering 5 million shares at $15, within the range of $14 to $16. Obalon Therapeutics plans to list on the Nasdaq under the...read more
Coming off a strong end to the third quarter, October is set to get off to a quick start with seven deals on the calendar in the week ahead. Investors will undoubtedly be paying close attention to the next notable tech deal, ...read more
Obalon Therapeutics, which is developing an intragastric medical device to assist with weight loss, announced terms for its IPO on Monday.
The Carlsbad, CA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16....read more
US IPO Weekly Recap: Another tech IPO pops in a week with 6 IPOs
Six companies went public, making it the year's second most-active week. Coupa Software was the latest software IPO to price above its range and pop on the first day (+85%) as IPO investors continue to embrace high growth and strong margins, offered at a...read more
Obalon Therapeutics prices IPO at $15, within the range
Obalon Therapeutics, which is commercializing an intragastric balloon device designed to assist with weight loss, raised $75 million by offering 5 million shares at $15, within the range of $14 to $16. Obalon Therapeutics plans to list on the Nasdaq under the...read more
US IPO Week Ahead: Seven deals slotted to raise $1 billion total
Coming off a strong end to the third quarter, October is set to get off to a quick start with seven deals on the calendar in the week ahead. Investors will undoubtedly be paying close attention to the next notable tech deal, ...read more
Medical device company Obalon Therapeutics sets terms for $75 million IPO
Obalon Therapeutics, which is developing an intragastric medical device to assist with weight loss, announced terms for its IPO on Monday. The Carlsbad, CA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16....read more